Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $6.4 million.

  • Abivax's Other Operating Expenses rose 64.68% to -$953,110 in Q2 2025 from the same period last year, while for Jun 2025 it was -$7.1 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 8.03% down from last year.
  • According to the latest figures from FY2024, Abivax's Other Operating Expenses is $6.4 million, which was down 8.03% from $6.9 million recorded in FY2023.
  • Abivax's 5-year Other Operating Expenses high stood at $14.4 million for FY2022, and its period low was $6.4 million during FY2024.
  • Over the past 3 years, Abivax's median Other Operating Expenses value was $6.9 million (recorded in 2023), while the average stood at $9.2 million.
  • Data for Abivax's Other Operating Expenses shows a maximum YoY crashed of 51.84% (in 2023) over the last 5 years.
  • Abivax's Other Operating Expenses (Yearly) stood at $14.4 million in 2022, then slumped by 51.84% to $6.9 million in 2023, then dropped by 8.03% to $6.4 million in 2024.